

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcomere organization (GO:0045214) | 9.29221940 |
| 2 | cardiac myofibril assembly (GO:0055003) | 9.05385862 |
| 3 | cilium or flagellum-dependent cell motility (GO:0001539) | 7.77734277 |
| 4 | myofibril assembly (GO:0030239) | 7.73995976 |
| 5 | motile cilium assembly (GO:0044458) | 7.61351113 |
| 6 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 7.51761456 |
| 7 | skeletal muscle contraction (GO:0003009) | 7.41749625 |
| 8 | actin-myosin filament sliding (GO:0033275) | 7.25060838 |
| 9 | muscle filament sliding (GO:0030049) | 7.25060838 |
| 10 | cardiac muscle contraction (GO:0060048) | 6.94950479 |
| 11 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 6.84398965 |
| 12 | cardiac muscle cell development (GO:0055013) | 6.43771213 |
| 13 | cilium movement (GO:0003341) | 6.37993223 |
| 14 | regulation of relaxation of muscle (GO:1901077) | 6.37507832 |
| 15 | regulation of actin filament-based movement (GO:1903115) | 6.15631798 |
| 16 | cardiac cell development (GO:0055006) | 6.05863616 |
| 17 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 6.05280299 |
| 18 | cardiac muscle tissue morphogenesis (GO:0055008) | 6.01905094 |
| 19 | actin-mediated cell contraction (GO:0070252) | 5.99601943 |
| 20 | actomyosin structure organization (GO:0031032) | 5.80131755 |
| 21 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 5.77199711 |
| 22 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.77142064 |
| 23 | tricarboxylic acid cycle (GO:0006099) | 5.71517910 |
| 24 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.70314374 |
| 25 | cardiac muscle hypertrophy (GO:0003300) | 5.68791234 |
| 26 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 5.66140443 |
| 27 | muscle tissue morphogenesis (GO:0060415) | 5.48495112 |
| 28 | adult heart development (GO:0007512) | 5.47130082 |
| 29 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.44128448 |
| 30 | striated muscle hypertrophy (GO:0014897) | 5.42736738 |
| 31 | heart trabecula formation (GO:0060347) | 5.39228516 |
| 32 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 5.32265571 |
| 33 | epithelial cilium movement (GO:0003351) | 5.30839901 |
| 34 | regulation of sarcomere organization (GO:0060297) | 5.28296409 |
| 35 | ventricular cardiac muscle cell action potential (GO:0086005) | 5.22921954 |
| 36 | striated muscle contraction (GO:0006941) | 5.22192541 |
| 37 | regulation of the force of heart contraction (GO:0002026) | 5.09711707 |
| 38 | plasma membrane repair (GO:0001778) | 5.04039063 |
| 39 | heart contraction (GO:0060047) | 4.94028008 |
| 40 | heart process (GO:0003015) | 4.94028008 |
| 41 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 4.90841570 |
| 42 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.89980957 |
| 43 | left/right pattern formation (GO:0060972) | 4.89584994 |
| 44 | regulation of striated muscle contraction (GO:0006942) | 4.84594979 |
| 45 | muscle hypertrophy (GO:0014896) | 4.83554899 |
| 46 | regulation of skeletal muscle contraction (GO:0014819) | 4.81661155 |
| 47 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.59044869 |
| 48 | skeletal muscle adaptation (GO:0043501) | 4.57294590 |
| 49 | actin filament-based movement (GO:0030048) | 4.55151779 |
| 50 | response to muscle activity (GO:0014850) | 4.54121920 |
| 51 | regulation of cardiac muscle cell contraction (GO:0086004) | 4.44396939 |
| 52 | regulation of cell communication by electrical coupling (GO:0010649) | 4.40017608 |
| 53 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.37899053 |
| 54 | regulation of cardioblast differentiation (GO:0051890) | 4.32431711 |
| 55 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 4.32147792 |
| 56 | carnitine shuttle (GO:0006853) | 4.31608855 |
| 57 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.29760030 |
| 58 | cell communication involved in cardiac conduction (GO:0086065) | 4.15000372 |
| 59 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.12927349 |
| 60 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.12383411 |
| 61 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.11618285 |
| 62 | axoneme assembly (GO:0035082) | 4.11598583 |
| 63 | regulation of membrane repolarization (GO:0060306) | 4.09680347 |
| 64 | regulation of cardiac muscle contraction (GO:0055117) | 4.04782635 |
| 65 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 4.00542141 |
| 66 | muscle hypertrophy in response to stress (GO:0003299) | 4.00542141 |
| 67 | cardiac muscle adaptation (GO:0014887) | 4.00542141 |
| 68 | regulation of ATP catabolic process (GO:1903289) | 3.99340048 |
| 69 | regulation of ATPase activity (GO:0043462) | 3.99340048 |
| 70 | ventricular cardiac muscle cell development (GO:0055015) | 3.98539855 |
| 71 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.90122412 |
| 72 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.83617781 |
| 73 | ATP synthesis coupled proton transport (GO:0015986) | 3.83617781 |
| 74 | negative regulation of potassium ion transport (GO:0043267) | 3.83048298 |
| 75 | relaxation of cardiac muscle (GO:0055119) | 3.82745754 |
| 76 | striated muscle atrophy (GO:0014891) | 3.82581887 |
| 77 | oxidative phosphorylation (GO:0006119) | 3.79753101 |
| 78 | regulation of cofactor metabolic process (GO:0051193) | 3.76841115 |
| 79 | regulation of coenzyme metabolic process (GO:0051196) | 3.76841115 |
| 80 | regulation of heart rate (GO:0002027) | 3.71702283 |
| 81 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.71400469 |
| 82 | fatty acid transmembrane transport (GO:1902001) | 3.68988945 |
| 83 | primary alcohol catabolic process (GO:0034310) | 3.67045131 |
| 84 | striated muscle cell development (GO:0055002) | 3.63053212 |
| 85 | oxygen transport (GO:0015671) | 3.62325223 |
| 86 | cell communication by electrical coupling (GO:0010644) | 3.60394150 |
| 87 | regulation of heart contraction (GO:0008016) | 3.60046976 |
| 88 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.56803794 |
| 89 | creatine metabolic process (GO:0006600) | 3.56552536 |
| 90 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.54385998 |
| 91 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.54014648 |
| 92 | cardiac muscle cell action potential (GO:0086001) | 3.50923941 |
| 93 | respiratory electron transport chain (GO:0022904) | 3.45254625 |
| 94 | regulation of muscle contraction (GO:0006937) | 3.39976160 |
| 95 | muscle adaptation (GO:0043500) | 3.37604900 |
| 96 | muscle contraction (GO:0006936) | 3.37314866 |
| 97 | 2-oxoglutarate metabolic process (GO:0006103) | 3.36821432 |
| 98 | trabecula formation (GO:0060343) | 3.36407595 |
| 99 | electron transport chain (GO:0022900) | 3.36090893 |
| 100 | cardiac chamber formation (GO:0003207) | 3.32489739 |
| 101 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.32437939 |
| 102 | negative regulation of protein localization to cell surface (GO:2000009) | 3.31396124 |
| 103 | ethanol metabolic process (GO:0006067) | 3.29926386 |
| 104 | regulation of striated muscle cell apoptotic process (GO:0010662) | 3.27125163 |
| 105 | regulation of germinal center formation (GO:0002634) | 3.26177741 |
| 106 | atrial septum morphogenesis (GO:0060413) | 3.25838093 |
| 107 | carnitine transmembrane transport (GO:1902603) | 3.25710912 |
| 108 | NADH metabolic process (GO:0006734) | 3.25020092 |
| 109 | skeletal muscle fiber development (GO:0048741) | 3.24771224 |
| 110 | muscle atrophy (GO:0014889) | 3.24335239 |
| 111 | cardiac conduction (GO:0061337) | 3.21949771 |
| 112 | striated muscle adaptation (GO:0014888) | 3.21890377 |
| 113 | muscle system process (GO:0003012) | 3.20901343 |
| 114 | positive regulation of heart contraction (GO:0045823) | 3.20791780 |
| 115 | muscle cell development (GO:0055001) | 3.17801113 |
| 116 | oxaloacetate metabolic process (GO:0006107) | 3.14642907 |
| 117 | positive regulation of cation channel activity (GO:2001259) | 3.10326608 |
| 118 | response to inactivity (GO:0014854) | 3.09862450 |
| 119 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.09035926 |
| 120 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.08513783 |
| 121 | atrioventricular valve morphogenesis (GO:0003181) | 3.08154178 |
| 122 | skeletal muscle tissue development (GO:0007519) | 3.06628959 |
| 123 | vitamin transmembrane transport (GO:0035461) | 3.05395949 |
| 124 | negative regulation of inclusion body assembly (GO:0090084) | 2.95750627 |
| 125 | glycogen catabolic process (GO:0005980) | 2.94275227 |
| 126 | myotube cell development (GO:0014904) | 2.92589195 |
| 127 | cytoplasmic microtubule organization (GO:0031122) | 2.92500210 |
| 128 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.92075701 |
| 129 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.92075701 |
| 130 | carnitine transport (GO:0015879) | 2.89801758 |
| 131 | amino-acid betaine transport (GO:0015838) | 2.89801758 |
| 132 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.89226926 |
| 133 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.89226926 |
| 134 | one-carbon compound transport (GO:0019755) | 2.86522569 |
| 135 | regulation of cilium movement (GO:0003352) | 2.82780542 |
| 136 | muscle fiber development (GO:0048747) | 2.77826638 |
| 137 | negative regulation of necroptotic process (GO:0060546) | 2.73966496 |
| 138 | sperm capacitation (GO:0048240) | 2.73614732 |
| 139 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.72910580 |
| 140 | glucan catabolic process (GO:0009251) | 2.72522447 |
| 141 | muscle cell cellular homeostasis (GO:0046716) | 2.72367502 |
| 142 | muscle cell fate commitment (GO:0042693) | 2.70619354 |
| 143 | muscle organ morphogenesis (GO:0048644) | 2.66046021 |
| 144 | axonemal dynein complex assembly (GO:0070286) | 10.0615685 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.51185716 |
| 2 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 4.51845673 |
| 3 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 3.78864747 |
| 4 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 3.78864747 |
| 5 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.66509625 |
| 6 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.61034192 |
| 7 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.48370196 |
| 8 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.44671014 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.33339665 |
| 10 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.96053385 |
| 11 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.85676062 |
| 12 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.75760608 |
| 13 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.61355687 |
| 14 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.60167462 |
| 15 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.38452320 |
| 16 | * CLOCK_20551151_ChIP-Seq_293T_Human | 2.32407626 |
| 17 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 2.31816217 |
| 18 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.31633819 |
| 19 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.29542705 |
| 20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.27450451 |
| 21 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 2.23517556 |
| 22 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.09970991 |
| 23 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.03755681 |
| 24 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.99058076 |
| 25 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.98320898 |
| 26 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.88277178 |
| 27 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.86799512 |
| 28 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.78868538 |
| 29 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.76139824 |
| 30 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.75853546 |
| 31 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.73450324 |
| 32 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.73212375 |
| 33 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.71763065 |
| 34 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.68165507 |
| 35 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.68097249 |
| 36 | MYC_22102868_ChIP-Seq_BL_Human | 1.66014655 |
| 37 | * MAF_26560356_Chip-Seq_TH1_Human | 1.63977403 |
| 38 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.63875138 |
| 39 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.62303560 |
| 40 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.61300977 |
| 41 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.57491271 |
| 42 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.53450880 |
| 43 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.52458264 |
| 44 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.51754318 |
| 45 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.51028549 |
| 46 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.49028693 |
| 47 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.42669058 |
| 48 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.42492568 |
| 49 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.41011604 |
| 50 | GATA1_19941826_ChIP-Seq_K562_Human | 1.40274700 |
| 51 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.40119023 |
| 52 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.39391089 |
| 53 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.38939889 |
| 54 | UTX_26944678_Chip-Seq_JUKART_Human | 1.36562780 |
| 55 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.31403037 |
| 56 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.30749668 |
| 57 | GATA1_22025678_ChIP-Seq_K562_Human | 1.29897285 |
| 58 | SPI1_23127762_ChIP-Seq_K562_Human | 1.29313600 |
| 59 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.29131398 |
| 60 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.28062950 |
| 61 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.27423867 |
| 62 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.27414233 |
| 63 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.27362484 |
| 64 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.26440303 |
| 65 | ATF3_27146783_Chip-Seq_COLON_Human | 1.25714941 |
| 66 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.24991834 |
| 67 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.24185614 |
| 68 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.23414884 |
| 69 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23035182 |
| 70 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.22769147 |
| 71 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.22206121 |
| 72 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.22167787 |
| 73 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.21857057 |
| 74 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.21246795 |
| 75 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.20361547 |
| 76 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.18425913 |
| 77 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.16526718 |
| 78 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.15875682 |
| 79 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.15295522 |
| 80 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.14913469 |
| 81 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.14111326 |
| 82 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.12824128 |
| 83 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.12516376 |
| 84 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.11101514 |
| 85 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.08377815 |
| 86 | GATA2_19941826_ChIP-Seq_K562_Human | 1.08269488 |
| 87 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.08138856 |
| 88 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.07671505 |
| 89 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.07625285 |
| 90 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.07264709 |
| 91 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.06872856 |
| 92 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.06143484 |
| 93 | P68_20966046_ChIP-Seq_HELA_Human | 1.04963462 |
| 94 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04660767 |
| 95 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.04070176 |
| 96 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.03410884 |
| 97 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.03259822 |
| 98 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.03252385 |
| 99 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.02632028 |
| 100 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.02516909 |
| 101 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.01612305 |
| 102 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.01313832 |
| 103 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.01231501 |
| 104 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.00792828 |
| 105 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.00480184 |
| 106 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.00247550 |
| 107 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.99831597 |
| 108 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.99527669 |
| 109 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.98782499 |
| 110 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.98179126 |
| 111 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.97587182 |
| 112 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.97585454 |
| 113 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.97030391 |
| 114 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.96708830 |
| 115 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.96453656 |
| 116 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.95962687 |
| 117 | SA1_27219007_Chip-Seq_Bcells_Human | 0.95806179 |
| 118 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.95095125 |
| 119 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95060007 |
| 120 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.94340999 |
| 121 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.94270294 |
| 122 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.94131936 |
| 123 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.93434245 |
| 124 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.93211461 |
| 125 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.92784786 |
| 126 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.92009663 |
| 127 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.91983746 |
| 128 | CJUN_26792858_Chip-Seq_BT549_Human | 0.91821391 |
| 129 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91648464 |
| 130 | KDM2B_26808549_Chip-Seq_K562_Human | 0.91219231 |
| 131 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.91075102 |
| 132 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.90137141 |
| 133 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.89331699 |
| 134 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.89248146 |
| 135 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88601356 |
| 136 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.88224887 |
| 137 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.87986543 |
| 138 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.87933017 |
| 139 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.87781766 |
| 140 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.87777592 |
| 141 | MYB_26560356_Chip-Seq_TH2_Human | 0.87653183 |
| 142 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.86943166 |
| 143 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.86896824 |
| 144 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.86393609 |
| 145 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.86133316 |
| 146 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.86058882 |
| 147 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.85944109 |
| 148 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.85823712 |
| 149 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.85723720 |
| 150 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.85350952 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 5.97787668 |
| 2 | MP0004084_abnormal_cardiac_muscle | 5.94332987 |
| 3 | MP0000751_myopathy | 4.78069940 |
| 4 | MP0003646_muscle_fatigue | 4.71412879 |
| 5 | MP0004215_abnormal_myocardial_fiber | 4.45629045 |
| 6 | MP0004036_abnormal_muscle_relaxation | 4.26950385 |
| 7 | MP0005330_cardiomyopathy | 4.07863035 |
| 8 | MP0000749_muscle_degeneration | 3.79423885 |
| 9 | * MP0002972_abnormal_cardiac_muscle | 3.16888474 |
| 10 | MP0008775_abnormal_heart_ventricle | 3.11882990 |
| 11 | MP0004510_myositis | 3.09484638 |
| 12 | MP0004087_abnormal_muscle_fiber | 3.04636010 |
| 13 | MP0003137_abnormal_impulse_conducting | 2.83878162 |
| 14 | MP0010630_abnormal_cardiac_muscle | 2.77647546 |
| 15 | MP0001544_abnormal_cardiovascular_syste | 2.70954734 |
| 16 | MP0005385_cardiovascular_system_phenoty | 2.70954734 |
| 17 | MP0000750_abnormal_muscle_regeneration | 2.65891212 |
| 18 | MP0003828_pulmonary_edema | 2.60789965 |
| 19 | MP0005620_abnormal_muscle_contractility | 2.59437102 |
| 20 | MP0006138_congestive_heart_failure | 2.52951917 |
| 21 | MP0002106_abnormal_muscle_physiology | 2.43115330 |
| 22 | MP0004484_altered_response_of | 2.40118037 |
| 23 | MP0004130_abnormal_muscle_cell | 2.14824486 |
| 24 | MP0004085_abnormal_heartbeat | 2.10041031 |
| 25 | MP0003221_abnormal_cardiomyocyte_apopto | 2.07246683 |
| 26 | MP0002269_muscular_atrophy | 2.06716316 |
| 27 | MP0005369_muscle_phenotype | 1.93077647 |
| 28 | MP0000747_muscle_weakness | 1.91885084 |
| 29 | MP0004145_abnormal_muscle_electrophysio | 1.79640831 |
| 30 | MP0000759_abnormal_skeletal_muscle | 1.76942564 |
| 31 | MP0002127_abnormal_cardiovascular_syste | 1.72097265 |
| 32 | MP0003279_aneurysm | 1.66562319 |
| 33 | MP0009780_abnormal_chondrocyte_physiolo | 1.63414178 |
| 34 | MP0004043_abnormal_pH_regulation | 1.62656993 |
| 35 | MP0003656_abnormal_erythrocyte_physiolo | 1.59237259 |
| 36 | MP0008875_abnormal_xenobiotic_pharmacok | 1.51041464 |
| 37 | MP0003950_abnormal_plasma_membrane | 1.48882994 |
| 38 | MP0006036_abnormal_mitochondrial_physio | 1.43595863 |
| 39 | MP0002132_abnormal_respiratory_system | 1.39828135 |
| 40 | MP0003567_abnormal_fetal_cardiomyocyte | 1.39298672 |
| 41 | MP0000343_altered_response_to | 1.36657707 |
| 42 | MP0002653_abnormal_ependyma_morphology | 1.31591732 |
| 43 | MP0004233_abnormal_muscle_weight | 1.31521439 |
| 44 | MP0010368_abnormal_lymphatic_system | 1.25452322 |
| 45 | MP0002332_abnormal_exercise_endurance | 1.22707949 |
| 46 | * MP0000266_abnormal_heart_morphology | 1.20327249 |
| 47 | MP0009840_abnormal_foam_cell | 1.18484898 |
| 48 | MP0005165_increased_susceptibility_to | 1.17403950 |
| 49 | MP0005666_abnormal_adipose_tissue | 1.11904538 |
| 50 | MP0008004_abnormal_stomach_pH | 1.06471300 |
| 51 | MP0003075_altered_response_to | 1.05294445 |
| 52 | MP0003566_abnormal_cell_adhesion | 1.03570467 |
| 53 | MP0003453_abnormal_keratinocyte_physiol | 0.99814177 |
| 54 | MP0002234_abnormal_pharynx_morphology | 0.98623938 |
| 55 | MP0002128_abnormal_blood_circulation | 0.97015535 |
| 56 | MP0005623_abnormal_meninges_morphology | 0.92608396 |
| 57 | MP0003806_abnormal_nucleotide_metabolis | 0.91397373 |
| 58 | MP0005670_abnormal_white_adipose | 0.90886571 |
| 59 | MP0005166_decreased_susceptibility_to | 0.89996825 |
| 60 | MP0005058_abnormal_lysosome_morphology | 0.88949431 |
| 61 | MP0009384_cardiac_valve_regurgitation | 0.88853873 |
| 62 | MP0005375_adipose_tissue_phenotype | 0.87410110 |
| 63 | MP0000733_abnormal_muscle_development | 0.87009270 |
| 64 | MP0005451_abnormal_body_composition | 0.86390442 |
| 65 | MP0000767_abnormal_smooth_muscle | 0.86303512 |
| 66 | MP0000013_abnormal_adipose_tissue | 0.85275845 |
| 67 | MP0002139_abnormal_hepatobiliary_system | 0.84098280 |
| 68 | MP0000230_abnormal_systemic_arterial | 0.83701685 |
| 69 | MP0001879_abnormal_lymphatic_vessel | 0.82638271 |
| 70 | MP0001853_heart_inflammation | 0.82183513 |
| 71 | MP0006082_CNS_inflammation | 0.80167860 |
| 72 | MP0005167_abnormal_blood-brain_barrier | 0.78502505 |
| 73 | MP0001984_abnormal_olfaction | 0.73660161 |
| 74 | MP0003191_abnormal_cellular_cholesterol | 0.73256476 |
| 75 | MP0004185_abnormal_adipocyte_glucose | 0.73139077 |
| 76 | MP0003122_maternal_imprinting | 0.72006275 |
| 77 | MP0004272_abnormal_basement_membrane | 0.71486522 |
| 78 | MP0006035_abnormal_mitochondrial_morpho | 0.68583410 |
| 79 | MP0002277_abnormal_respiratory_mucosa | 0.67484248 |
| 80 | MP0005083_abnormal_biliary_tract | 0.67271472 |
| 81 | MP0002108_abnormal_muscle_morphology | 0.67062673 |
| 82 | MP0002148_abnormal_hypersensitivity_rea | 0.65513127 |
| 83 | MP0000003_abnormal_adipose_tissue | 0.65065847 |
| 84 | MP0000685_abnormal_immune_system | 0.64319296 |
| 85 | MP0002925_abnormal_cardiovascular_devel | 0.63126594 |
| 86 | MP0008961_abnormal_basal_metabolism | 0.62894579 |
| 87 | MP0002168_other_aberrant_phenotype | 0.61962614 |
| 88 | MP0003705_abnormal_hypodermis_morpholog | 0.61338760 |
| 89 | MP0003763_abnormal_thymus_physiology | 0.59013850 |
| 90 | MP0005164_abnormal_response_to | 0.58193085 |
| 91 | MP0005023_abnormal_wound_healing | 0.58070699 |
| 92 | MP0002933_joint_inflammation | 0.57496393 |
| 93 | MP0003303_peritoneal_inflammation | 0.53570494 |
| 94 | MP0002166_altered_tumor_susceptibility | 0.53469225 |
| 95 | MP0005266_abnormal_metabolism | 0.52325050 |
| 96 | MP0001614_abnormal_blood_vessel | 0.51977831 |
| 97 | MP0002998_abnormal_bone_remodeling | 0.51417321 |
| 98 | MP0001784_abnormal_fluid_regulation | 0.51330648 |
| 99 | MP0003879_abnormal_hair_cell | 0.50144994 |
| 100 | MP0000249_abnormal_blood_vessel | 0.49448837 |
| 101 | MP0008438_abnormal_cutaneous_collagen | 0.49272766 |
| 102 | MP0002896_abnormal_bone_mineralization | 0.49114941 |
| 103 | MP0005376_homeostasis/metabolism_phenot | 0.48974852 |
| 104 | MP0002909_abnormal_adrenal_gland | 0.48813506 |
| 105 | MP0002088_abnormal_embryonic_growth/wei | 0.48709261 |
| 106 | MP0009764_decreased_sensitivity_to | 0.48576424 |
| 107 | MP0004808_abnormal_hematopoietic_stem | 0.47948047 |
| 108 | MP0003984_embryonic_growth_retardation | 0.47685979 |
| 109 | MP0009785_altered_susceptibility_to | 0.46364533 |
| 110 | MP0001765_abnormal_ion_homeostasis | 0.45515212 |
| 111 | MP0003436_decreased_susceptibility_to | 0.45456620 |
| 112 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.44776359 |
| 113 | MP0000858_altered_metastatic_potential | 0.43200811 |
| 114 | MP0009278_abnormal_bone_marrow | 0.43160681 |
| 115 | MP0010155_abnormal_intestine_physiology | 0.42143404 |
| 116 | MP0009763_increased_sensitivity_to | 0.41333461 |
| 117 | MP0008874_decreased_physiological_sensi | 0.40992629 |
| 118 | MP0000678_abnormal_parathyroid_gland | 0.40710908 |
| 119 | MP0003941_abnormal_skin_development | 0.39217200 |
| 120 | MP0002971_abnormal_brown_adipose | 0.38528539 |
| 121 | MP0005319_abnormal_enzyme/_coenzyme | 0.37091628 |
| 122 | MP0003091_abnormal_cell_migration | 0.36875632 |
| 123 | MP0003948_abnormal_gas_homeostasis | 0.34782066 |
| 124 | MP0001727_abnormal_embryo_implantation | 0.34475246 |
| 125 | MP0005275_abnormal_skin_tensile | 0.34048296 |
| 126 | MP0003300_gastrointestinal_ulcer | 0.33952621 |
| 127 | MP0001958_emphysema | 0.32812043 |
| 128 | MP0001790_abnormal_immune_system | 0.31705707 |
| 129 | MP0005387_immune_system_phenotype | 0.31705707 |
| 130 | MP0003724_increased_susceptibility_to | 0.31489184 |
| 131 | MP0003045_fibrosis | 0.30710224 |
| 132 | MP0001835_abnormal_antigen_presentation | 0.30130198 |
| 133 | MP0002877_abnormal_melanocyte_morpholog | 0.29567536 |
| 134 | MP0005595_abnormal_vascular_smooth | 0.28173182 |
| 135 | MP0006054_spinal_hemorrhage | 0.27976739 |
| 136 | MP0002078_abnormal_glucose_homeostasis | 0.27621244 |
| 137 | MP0002133_abnormal_respiratory_system | 0.25399006 |
| 138 | MP0005388_respiratory_system_phenotype | 0.25399006 |
| 139 | MP0001800_abnormal_humoral_immune | 0.24202806 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 8.17461038 |
| 2 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 7.14338447 |
| 3 | Ventricular tachycardia (HP:0004756) | 7.04706045 |
| 4 | Abnormal respiratory motile cilium morphology (HP:0005938) | 6.45098339 |
| 5 | Abnormal respiratory epithelium morphology (HP:0012253) | 6.45098339 |
| 6 | Absent/shortened dynein arms (HP:0200106) | 6.28723676 |
| 7 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 6.28723676 |
| 8 | Atrial fibrillation (HP:0005110) | 6.27040156 |
| 9 | Abnormal respiratory motile cilium physiology (HP:0012261) | 6.22599028 |
| 10 | Abnormal ciliary motility (HP:0012262) | 6.11204167 |
| 11 | Calf muscle hypertrophy (HP:0008981) | 6.10339464 |
| 12 | Primary atrial arrhythmia (HP:0001692) | 5.88587556 |
| 13 | Exercise-induced muscle cramps (HP:0003710) | 5.83058970 |
| 14 | Rhinitis (HP:0012384) | 5.78290360 |
| 15 | Supraventricular tachycardia (HP:0004755) | 5.71845003 |
| 16 | Lipoatrophy (HP:0100578) | 5.68209313 |
| 17 | Supraventricular arrhythmia (HP:0005115) | 5.62415607 |
| 18 | Exercise-induced myalgia (HP:0003738) | 5.54077040 |
| 19 | Muscle fiber splitting (HP:0003555) | 5.51403622 |
| 20 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.43781369 |
| 21 | Abnormality of the left ventricular outflow tract (HP:0011103) | 5.41619362 |
| 22 | Subaortic stenosis (HP:0001682) | 5.41619362 |
| 23 | Abnormality of the calf musculature (HP:0001430) | 5.33412888 |
| 24 | Right ventricular cardiomyopathy (HP:0011663) | 5.13878389 |
| 25 | Hyporeflexia of lower limbs (HP:0002600) | 5.02703422 |
| 26 | Syncope (HP:0001279) | 4.84110816 |
| 27 | Myoglobinuria (HP:0002913) | 4.64076443 |
| 28 | Dilated cardiomyopathy (HP:0001644) | 4.60785951 |
| 29 | Palpitations (HP:0001962) | 4.49222298 |
| 30 | Nasal polyposis (HP:0100582) | 4.46362559 |
| 31 | Bundle branch block (HP:0011710) | 4.31913135 |
| 32 | Prolonged QT interval (HP:0001657) | 4.24273790 |
| 33 | Ventricular arrhythmia (HP:0004308) | 4.23994469 |
| 34 | Chronic bronchitis (HP:0004469) | 4.22425073 |
| 35 | EMG: myopathic abnormalities (HP:0003458) | 4.20980034 |
| 36 | Bronchiectasis (HP:0002110) | 4.06227397 |
| 37 | Abnormality of the nasal mucosa (HP:0000433) | 3.98441416 |
| 38 | Asymmetric septal hypertrophy (HP:0001670) | 3.96436682 |
| 39 | Myopathic facies (HP:0002058) | 3.76876447 |
| 40 | Atrioventricular block (HP:0001678) | 3.74176323 |
| 41 | Heart block (HP:0012722) | 3.69684705 |
| 42 | Rhabdomyolysis (HP:0003201) | 3.66623574 |
| 43 | Ventricular fibrillation (HP:0001663) | 3.64922210 |
| 44 | Increased connective tissue (HP:0009025) | 3.64461500 |
| 45 | Abnormal atrioventricular conduction (HP:0005150) | 3.52634780 |
| 46 | Distal arthrogryposis (HP:0005684) | 3.15713691 |
| 47 | Abnormal EKG (HP:0003115) | 3.13368576 |
| 48 | Myotonia (HP:0002486) | 3.08475612 |
| 49 | Left ventricular hypertrophy (HP:0001712) | 3.07286346 |
| 50 | Difficulty running (HP:0009046) | 3.02088660 |
| 51 | Type 1 muscle fiber predominance (HP:0003803) | 2.98162607 |
| 52 | Ulnar deviation of the wrist (HP:0003049) | 2.96047432 |
| 53 | Round ear (HP:0100830) | 2.90838105 |
| 54 | Distal lower limb muscle weakness (HP:0009053) | 2.80736029 |
| 55 | Difficulty climbing stairs (HP:0003551) | 2.73556582 |
| 56 | Palmoplantar keratoderma (HP:0000982) | 2.66337109 |
| 57 | Hepatic necrosis (HP:0002605) | 2.65537407 |
| 58 | Ragged-red muscle fibers (HP:0003200) | 2.64474117 |
| 59 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.54758203 |
| 60 | Limb-girdle muscle atrophy (HP:0003797) | 2.52330901 |
| 61 | Increased variability in muscle fiber diameter (HP:0003557) | 2.51142747 |
| 62 | Neck muscle weakness (HP:0000467) | 2.51106215 |
| 63 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.50295862 |
| 64 | Infertility (HP:0000789) | 2.46214416 |
| 65 | Male infertility (HP:0003251) | 2.44988444 |
| 66 | Areflexia of lower limbs (HP:0002522) | 2.44295613 |
| 67 | Acute necrotizing encephalopathy (HP:0006965) | 2.42465658 |
| 68 | Recurrent sinusitis (HP:0011108) | 2.41760209 |
| 69 | Muscle fiber inclusion bodies (HP:0100299) | 2.39699798 |
| 70 | Hepatocellular necrosis (HP:0001404) | 2.36808243 |
| 71 | Sudden cardiac death (HP:0001645) | 2.35938239 |
| 72 | Conjunctival hamartoma (HP:0100780) | 2.34029046 |
| 73 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.33213913 |
| 74 | Hyperkalemia (HP:0002153) | 2.29762324 |
| 75 | Bulbar palsy (HP:0001283) | 2.28948533 |
| 76 | Bronchitis (HP:0012387) | 2.23484764 |
| 77 | Frequent falls (HP:0002359) | 2.23054497 |
| 78 | Increased muscle lipid content (HP:0009058) | 2.22127000 |
| 79 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.21529283 |
| 80 | Double outlet right ventricle (HP:0001719) | 2.21179352 |
| 81 | Congenital malformation of the right heart (HP:0011723) | 2.21179352 |
| 82 | Ketoacidosis (HP:0001993) | 2.20004661 |
| 83 | Abnormality of the foot musculature (HP:0001436) | 2.17129007 |
| 84 | Muscle stiffness (HP:0003552) | 2.16367233 |
| 85 | Broad metatarsal (HP:0001783) | 2.15101811 |
| 86 | Generalized muscle weakness (HP:0003324) | 2.14934432 |
| 87 | Fetal akinesia sequence (HP:0001989) | 2.14634457 |
| 88 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.13227183 |
| 89 | Recurrent otitis media (HP:0000403) | 2.13020927 |
| 90 | Testicular atrophy (HP:0000029) | 2.12989296 |
| 91 | Atelectasis (HP:0100750) | 2.12385355 |
| 92 | Congestive heart failure (HP:0001635) | 2.11191373 |
| 93 | Mitochondrial inheritance (HP:0001427) | 2.09468819 |
| 94 | Chronic sinusitis (HP:0011109) | 2.08052162 |
| 95 | Acute encephalopathy (HP:0006846) | 2.02118778 |
| 96 | Increased CSF lactate (HP:0002490) | 2.01404978 |
| 97 | Scapular winging (HP:0003691) | 2.00990600 |
| 98 | Exercise intolerance (HP:0003546) | 1.99528390 |
| 99 | Distal lower limb amyotrophy (HP:0008944) | 1.97802381 |
| 100 | Cerebral aneurysm (HP:0004944) | 1.97147633 |
| 101 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.97034327 |
| 102 | Gowers sign (HP:0003391) | 1.97009866 |
| 103 | Foot dorsiflexor weakness (HP:0009027) | 1.96925860 |
| 104 | Esophageal neoplasm (HP:0100751) | 1.96623098 |
| 105 | Neoplasm of head and neck (HP:0012288) | 1.96623098 |
| 106 | Diaphragmatic weakness (HP:0009113) | 1.96506050 |
| 107 | Progressive macrocephaly (HP:0004481) | 1.96477623 |
| 108 | Rimmed vacuoles (HP:0003805) | 1.95085381 |
| 109 | Hypoglycemic coma (HP:0001325) | 1.94472533 |
| 110 | Facial diplegia (HP:0001349) | 1.93114079 |
| 111 | Pheochromocytoma (HP:0002666) | 1.92021989 |
| 112 | Malignant hyperthermia (HP:0002047) | 1.91880706 |
| 113 | Increased intramyocellular lipid droplets (HP:0012240) | 1.90073815 |
| 114 | Dicarboxylic aciduria (HP:0003215) | 1.89860245 |
| 115 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.89860245 |
| 116 | Pulmonary artery stenosis (HP:0004415) | 1.89198643 |
| 117 | Proximal amyotrophy (HP:0007126) | 1.88254978 |
| 118 | EMG: neuropathic changes (HP:0003445) | 1.88229237 |
| 119 | Nemaline bodies (HP:0003798) | 1.87847979 |
| 120 | Lactic acidosis (HP:0003128) | 1.84412796 |
| 121 | Neoplasm of the adrenal gland (HP:0100631) | 1.83502806 |
| 122 | Calcaneovalgus deformity (HP:0001848) | 1.82753677 |
| 123 | Popliteal pterygium (HP:0009756) | 1.82747110 |
| 124 | Hip contracture (HP:0003273) | 1.82149388 |
| 125 | Hypoplastic left heart (HP:0004383) | 1.80459191 |
| 126 | Aplasia of the musculature (HP:0100854) | 1.79011028 |
| 127 | Respiratory failure (HP:0002878) | 1.78312526 |
| 128 | Cerebral edema (HP:0002181) | 1.77995334 |
| 129 | Muscular dystrophy (HP:0003560) | 1.77849061 |
| 130 | Hyperactive renin-angiotensin system (HP:0000841) | 1.74077090 |
| 131 | Neuroendocrine neoplasm (HP:0100634) | 1.73033391 |
| 132 | Dysmetric saccades (HP:0000641) | 1.71743119 |
| 133 | Lower limb amyotrophy (HP:0007210) | 1.69627261 |
| 134 | Progressive muscle weakness (HP:0003323) | 1.68947280 |
| 135 | Spinal rigidity (HP:0003306) | 1.68838939 |
| 136 | Abnormality of the endocardium (HP:0004306) | 1.68422010 |
| 137 | Absent phalangeal crease (HP:0006109) | 1.68368399 |
| 138 | Waddling gait (HP:0002515) | 1.68060855 |
| 139 | Hyperalaninemia (HP:0003348) | 1.67952733 |
| 140 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.62831392 |
| 141 | Bell-shaped thorax (HP:0001591) | 1.59893364 |
| 142 | Deformed tarsal bones (HP:0008119) | 1.58824856 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 5.22408085 |
| 2 | MYLK | 5.08463521 |
| 3 | MAPK15 | 4.76833914 |
| 4 | OBSCN | 4.62590933 |
| 5 | PKN2 | 3.65846727 |
| 6 | DMPK | 3.35232005 |
| 7 | TRIB3 | 3.07455596 |
| 8 | LMTK2 | 2.97572129 |
| 9 | PHKG1 | 2.82597425 |
| 10 | PHKG2 | 2.82597425 |
| 11 | PDK4 | 2.47669402 |
| 12 | PDK3 | 2.47669402 |
| 13 | STK24 | 2.46492145 |
| 14 | MUSK | 2.16931731 |
| 15 | PIK3CA | 2.10007156 |
| 16 | EPHA2 | 2.04813598 |
| 17 | TIE1 | 2.02890657 |
| 18 | GRK7 | 1.98099198 |
| 19 | BCKDK | 1.76198408 |
| 20 | TAOK2 | 1.68525887 |
| 21 | PIK3CG | 1.50024523 |
| 22 | ILK | 1.45264686 |
| 23 | TAOK1 | 1.42158673 |
| 24 | MAP4K1 | 1.35893973 |
| 25 | MST4 | 1.35198416 |
| 26 | IRAK3 | 1.33162814 |
| 27 | PDK2 | 1.30830351 |
| 28 | MOS | 1.29818737 |
| 29 | PAK3 | 1.29633672 |
| 30 | FLT3 | 1.29248125 |
| 31 | ZAK | 1.22370650 |
| 32 | TGFBR2 | 1.21290645 |
| 33 | PRKD1 | 1.19587036 |
| 34 | CDC42BPA | 1.14684205 |
| 35 | NEK1 | 1.12790367 |
| 36 | NME1 | 1.12376402 |
| 37 | DAPK3 | 1.10949739 |
| 38 | MAP3K7 | 1.08738451 |
| 39 | EPHB1 | 1.08516159 |
| 40 | CAMK2D | 1.07754588 |
| 41 | PINK1 | 1.06609132 |
| 42 | KDR | 1.05320343 |
| 43 | MAP2K3 | 1.04957965 |
| 44 | ROCK1 | 1.01924319 |
| 45 | ICK | 0.98562715 |
| 46 | TBK1 | 0.98246057 |
| 47 | TYK2 | 0.94210486 |
| 48 | MAPKAPK3 | 0.93743103 |
| 49 | TESK1 | 0.92068877 |
| 50 | RIPK1 | 0.90379112 |
| 51 | JAK1 | 0.89237207 |
| 52 | PIM2 | 0.86890125 |
| 53 | MAPK12 | 0.86496029 |
| 54 | MAP2K6 | 0.86243012 |
| 55 | MAP3K10 | 0.84322935 |
| 56 | STK4 | 0.82318328 |
| 57 | FGFR4 | 0.82099305 |
| 58 | DDR2 | 0.80718698 |
| 59 | MAP3K5 | 0.80663020 |
| 60 | MAP3K3 | 0.79807760 |
| 61 | TRPM7 | 0.76200353 |
| 62 | DYRK1B | 0.76020383 |
| 63 | STK38L | 0.75713897 |
| 64 | PDGFRA | 0.75123215 |
| 65 | PKN1 | 0.74836806 |
| 66 | EPHA3 | 0.72076825 |
| 67 | MAP3K1 | 0.71313875 |
| 68 | CSK | 0.71183291 |
| 69 | ITK | 0.70755535 |
| 70 | PRKAA2 | 0.69744318 |
| 71 | LATS2 | 0.69400599 |
| 72 | LRRK2 | 0.68220633 |
| 73 | PTK6 | 0.67349453 |
| 74 | MARK2 | 0.66821519 |
| 75 | ZAP70 | 0.64756503 |
| 76 | CAMK4 | 0.64516313 |
| 77 | PTK2B | 0.64463263 |
| 78 | RPS6KL1 | 0.64438499 |
| 79 | RPS6KC1 | 0.64438499 |
| 80 | PRPF4B | 0.62954823 |
| 81 | RPS6KA6 | 0.62887962 |
| 82 | CAMK1 | 0.62375576 |
| 83 | NME2 | 0.60426156 |
| 84 | ABL2 | 0.60080505 |
| 85 | SMG1 | 0.59668573 |
| 86 | ARAF | 0.59532857 |
| 87 | PAK2 | 0.59343122 |
| 88 | MAP3K6 | 0.58844653 |
| 89 | ROCK2 | 0.56954528 |
| 90 | NEK9 | 0.56465697 |
| 91 | JAK3 | 0.55515200 |
| 92 | WNK4 | 0.55204080 |
| 93 | MAPK4 | 0.54300514 |
| 94 | MAPK7 | 0.54065024 |
| 95 | * CAMK2G | 0.53665466 |
| 96 | KIT | 0.52486496 |
| 97 | PRKAA1 | 0.50429662 |
| 98 | MAP3K13 | 0.48770623 |
| 99 | RPS6KA1 | 0.46037591 |
| 100 | MAP3K2 | 0.46037342 |
| 101 | TXK | 0.45214093 |
| 102 | STK10 | 0.42582531 |
| 103 | LIMK1 | 0.41912878 |
| 104 | EEF2K | 0.39259807 |
| 105 | RPS6KA2 | 0.39149662 |
| 106 | TGFBR1 | 0.39066533 |
| 107 | MAP2K4 | 0.38307289 |
| 108 | MST1R | 0.38204626 |
| 109 | MAP3K11 | 0.37995085 |
| 110 | FGFR3 | 0.36545958 |
| 111 | PRKCH | 0.36263625 |
| 112 | MAP3K14 | 0.36254342 |
| 113 | JAK2 | 0.36103559 |
| 114 | MAP2K1 | 0.34926156 |
| 115 | IKBKB | 0.33358186 |
| 116 | NLK | 0.32725909 |
| 117 | PRKACB | 0.31892584 |
| 118 | MAPKAPK2 | 0.30592877 |
| 119 | PDK1 | 0.30151418 |
| 120 | PRKG1 | 0.29762060 |
| 121 | IKBKE | 0.29290472 |
| 122 | MARK3 | 0.28548737 |
| 123 | PRKACG | 0.26355500 |
| 124 | CHUK | 0.25708950 |
| 125 | PRKG2 | 0.25399085 |
| 126 | * PRKACA | 0.25241904 |
| 127 | RET | 0.25048900 |
| 128 | CAMK2B | 0.24967720 |
| 129 | * CAMK2A | 0.24965513 |
| 130 | PDGFRB | 0.24938411 |
| 131 | ERBB3 | 0.24875860 |
| 132 | RPS6KA5 | 0.24821201 |
| 133 | STK38 | 0.24442644 |
| 134 | AKT2 | 0.23943457 |
| 135 | ERN1 | 0.23939875 |
| 136 | PRKCQ | 0.23400082 |
| 137 | MAPK11 | 0.23282500 |
| 138 | SIK1 | 0.22184781 |
| 139 | BTK | 0.21364966 |
| 140 | CCNB1 | 0.21136464 |
| 141 | PDPK1 | 0.21018402 |
| 142 | BLK | 0.20412602 |
| 143 | KSR2 | 0.20187091 |
| 144 | RPS6KB2 | 0.20030512 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.57213973 |
| 2 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.46814780 |
| 3 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 4.17676777 |
| 4 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 4.01099020 |
| 5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.69258548 |
| 6 | Parkinsons disease_Homo sapiens_hsa05012 | 3.13581912 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.03996601 |
| 8 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.87822187 |
| 9 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.61201356 |
| 10 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.47746486 |
| 11 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.23678305 |
| 12 | Viral myocarditis_Homo sapiens_hsa05416 | 2.22513204 |
| 13 | Alzheimers disease_Homo sapiens_hsa05010 | 2.20763825 |
| 14 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.19359018 |
| 15 | Carbon metabolism_Homo sapiens_hsa01200 | 2.10324646 |
| 16 | Huntingtons disease_Homo sapiens_hsa05016 | 1.85354796 |
| 17 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.85234850 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 1.84797329 |
| 19 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.78340154 |
| 20 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.72566691 |
| 21 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.56819176 |
| 22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.48004393 |
| 23 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.34824206 |
| 24 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.30282975 |
| 25 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.23921456 |
| 26 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.22564644 |
| 27 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.22488221 |
| 28 | Insulin resistance_Homo sapiens_hsa04931 | 1.20005397 |
| 29 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.16336199 |
| 30 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.14968068 |
| 31 | Focal adhesion_Homo sapiens_hsa04510 | 1.11110421 |
| 32 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.10763670 |
| 33 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.10328399 |
| 34 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.09905300 |
| 35 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.07854227 |
| 36 | Other glycan degradation_Homo sapiens_hsa00511 | 1.06353521 |
| 37 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.99149432 |
| 38 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.92028438 |
| 39 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.89719702 |
| 40 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.87489678 |
| 41 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.85968042 |
| 42 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.85847009 |
| 43 | Prion diseases_Homo sapiens_hsa05020 | 0.84921279 |
| 44 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.82808003 |
| 45 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.82471163 |
| 46 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.81176634 |
| 47 | Pertussis_Homo sapiens_hsa05133 | 0.80860934 |
| 48 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.80203492 |
| 49 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.78523364 |
| 50 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.76507624 |
| 51 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.76231288 |
| 52 | Lysosome_Homo sapiens_hsa04142 | 0.74927285 |
| 53 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.74824693 |
| 54 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.72577104 |
| 55 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.72361455 |
| 56 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.71946295 |
| 57 | Galactose metabolism_Homo sapiens_hsa00052 | 0.71410973 |
| 58 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.68561752 |
| 59 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.68483883 |
| 60 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.64826988 |
| 61 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.63918499 |
| 62 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.61832188 |
| 63 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.60998825 |
| 64 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.58540893 |
| 65 | Platelet activation_Homo sapiens_hsa04611 | 0.58246430 |
| 66 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.58104955 |
| 67 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.57898790 |
| 68 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.57167739 |
| 69 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.57096670 |
| 70 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.56222004 |
| 71 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.56015272 |
| 72 | Amoebiasis_Homo sapiens_hsa05146 | 0.55657065 |
| 73 | Renin secretion_Homo sapiens_hsa04924 | 0.55476909 |
| 74 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.54744541 |
| 75 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.53767088 |
| 76 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.53602017 |
| 77 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.53487373 |
| 78 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.53409337 |
| 79 | Leishmaniasis_Homo sapiens_hsa05140 | 0.52918803 |
| 80 | Adherens junction_Homo sapiens_hsa04520 | 0.51729896 |
| 81 | Salivary secretion_Homo sapiens_hsa04970 | 0.50705055 |
| 82 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.50460969 |
| 83 | Lysine degradation_Homo sapiens_hsa00310 | 0.49252505 |
| 84 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.48572285 |
| 85 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.48552241 |
| 86 | Tight junction_Homo sapiens_hsa04530 | 0.48295054 |
| 87 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.47869245 |
| 88 | Hepatitis C_Homo sapiens_hsa05160 | 0.47623477 |
| 89 | Bladder cancer_Homo sapiens_hsa05219 | 0.46317487 |
| 90 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.45908717 |
| 91 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.44654782 |
| 92 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.44484243 |
| 93 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.43846985 |
| 94 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.43625993 |
| 95 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.43227116 |
| 96 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.43163871 |
| 97 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.41279220 |
| 98 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.40597439 |
| 99 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.39837485 |
| 100 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.39240586 |
| 101 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.38844982 |
| 102 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.38746331 |
| 103 | Measles_Homo sapiens_hsa05162 | 0.37859538 |
| 104 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.37853981 |
| 105 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.37133875 |
| 106 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.37105387 |
| 107 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.35798760 |
| 108 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.35036059 |
| 109 | Tuberculosis_Homo sapiens_hsa05152 | 0.34774870 |
| 110 | Peroxisome_Homo sapiens_hsa04146 | 0.34547092 |
| 111 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.34268414 |
| 112 | Legionellosis_Homo sapiens_hsa05134 | 0.34039092 |
| 113 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.31842845 |
| 114 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.31389052 |
| 115 | Circadian rhythm_Homo sapiens_hsa04710 | 0.31265537 |
| 116 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.31088575 |
| 117 | ABC transporters_Homo sapiens_hsa02010 | 0.30515280 |
| 118 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.30268691 |
| 119 | HTLV-I infection_Homo sapiens_hsa05166 | 0.30063520 |
| 120 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.29655413 |
| 121 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.29364756 |
| 122 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.27031080 |
| 123 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.25243893 |
| 124 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.24497667 |
| 125 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.23040235 |
| 126 | Salmonella infection_Homo sapiens_hsa05132 | 0.21327745 |
| 127 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.21239372 |
| 128 | Apoptosis_Homo sapiens_hsa04210 | 0.19888379 |
| 129 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.19128518 |
| 130 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.18071271 |
| 131 | Malaria_Homo sapiens_hsa05144 | 0.18041274 |
| 132 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.17979075 |
| 133 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.17664704 |
| 134 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.17425276 |
| 135 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.16784357 |
| 136 | Pathways in cancer_Homo sapiens_hsa05200 | 0.15798233 |
| 137 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.15078296 |
| 138 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.14730168 |
| 139 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.14542545 |

